CBPLPharmaceuticals
Chandra Bhagat Pharma Ltd — PE Ratio & Valuation Analysis
₹30.50
-4.77%
Current P/E47.10xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E32.3x45.8% above avg
⚠️
48.3% Premium to Industry
CBPL P/E 47.10x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹2.03 | ₹66 | 32.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Chandra Bhagat Pharma Ltd Valuation
Chandra Bhagat Pharma Ltd (CBPL) currently trades at 47.10x earnings. The Pharmaceuticals sector average PE is 31.77x. CBPL commands a premium, reflecting high growth expectations. Historically, CBPL has traded at an average PE of 32.3x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
2.41%
Dividend Yield
0.00%
More on Chandra Bhagat Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.